Page 4 - Pershing Square Foundation News Today

The Steinsaltz Portal is a comprehensive treasure trove of the rabbi’s books, classes, and articles, all fully digitized and preserved for future generations.

The Oxford Pershing Square Graduate Scholarships 2024-2025 in the UK is one of the prestigious scholarships for international students.

Bill Ackman, Founder and CEO of Pershing Square Capital Management.

A team of researchers led by Feng Zhang at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard has uncovered the first programmable RNA-guided system in eukaryotes — organisms that include fungi, plants, and an

The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems

A team of researchers led by Feng Zhang at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT has uncovered the first programmable RNA-guided system in eukaryotes — organisms that include fungi, plants, and animals. In a study in Nature, the team describes how the system is based on a protein called Fanzor. They showed that Fanzor proteins use RNA as a guide to target DNA precisely, and that Fanzors can be reprogrammed to edit the genome of human cells....

Researchers have discovered the first programmable RNA-guided system discovered in eukaryotes. The technology, known as Fanzor, has the potential to be more easily delivered to cells and tissues than CRISPR-Cas systems, and further refinements could make them a valuable new technology for human genome editing.

Signature Theatre has revealed its Winter/Spring 2024 season, with work from resident playwrights Dominique Morisseau, Sarah Ruhl, and Dave Malloy.

Signature Theatre announces the cast and creative team of its world premiere production of MacArthur Fellow Branden Jacobs-Jenkins' The Comeuppance, directed by Eric Ting. Concluding Jacobs-Jenkins' Premiere Residency—and Signature's 2022-2023 season of personal and profound works from its Resident writers—The Comeuppance runs May 16–June 25.

Researchers have developed a new protein delivery approach that works in human cells and animals. The system could be a safe and efficient way to deliver gene therapies and cancer therapies.